Skill-Building Approach for Opioid Abuse
(ISLA Trial)
Trial Summary
What is the purpose of this trial?
This project will test the effectiveness of the Inclusive Skill-building Learning Approach (ISLA) in reducing the use of exclusionary discipline, improving teacher practice and student outcomes, and decreasing substance misuse using a randomized controlled trial in 60 middle schools across six states.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Instructional Skill-Building Learning Approach (ISLA) for opioid abuse?
The IOTOD conference, an educational initiative, has shown that healthcare professionals are increasingly positive about incorporating individualized treatment plans and psychosocial interventions for opioid dependence, suggesting that educational approaches like ISLA may be effective in changing attitudes and practices in opioid abuse treatment.12345
How is the ISLA treatment different from other treatments for opioid abuse?
Eligibility Criteria
This trial is for educators (administrators, teachers, instructional assistants, school counselors) in middle schools who have regular contact with students. Participants will be from 60 different schools across six states and must consent to provide data through annual surveys at three time points over two years.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Data Collection
Baseline data collection occurs before the implementation of ISLA
Treatment
Implementation of ISLA in schools, with training and support for school staff
Follow-up
Participants are monitored for effectiveness of ISLA on student outcomes and substance misuse
Treatment Details
Interventions
- Instructional Skill-Building Learning Approach (ISLA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oregon
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator